Jump to content

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Madrid
  • Quirónsalud
  • Doubts and Queries
  • Site Map
  • twitter This link will open in a pop-up window.
  • facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
  • TikTok Link to external application.
  • Researcher Portal Link to external application.
Language selector
Active language English
  • español
  • English
  • Institute
    • Institute
    • Objetives
    • Organisational Structure
    • Documents
    • Strategy HRS4R
    • Transparency Portal
  • Research Areas and Groups
  • Scientific Activity
    • Summary of Scientific Activity
    • Most relevant publications
    • Attracting resources
    • Collaborative research
    • European Projects
  • Support Units
    • Research Management Area
    • Research Support Units
    • Clinical trials
  • Training and Employment
    • Employment offers
    • Training plan
  • Current events
    • News
    • Videos
    • Health content
  • Innovation
    • Who are we?
    • Do you have an idea?
    • Portfolio of services
    • Our technological offers
    • Our successful cases
    • Innovation Committee
    • Documents
    • Clinical Practice Guidelines
  • Location and Contact
  • Colabora con la investigación
  • Portal comunicación interna
  • Home
  •   |   Innovation
  •   |   4. OUR TECHNOLOGICAL OFFER
  •   |   Pharma. New treatment methods and advanced therapies
  • Print
  • Tweet
  • Share on Facebook
  • Share on Linkedin
  • Share on WhatsApp

Pharma. New treatment methods and advanced therapies

  • New treatment for Chronic Kidney Disease based on Aging New treatment for Chronic Kidney Disease based on Aging (329 KB ) (1 page)
  • New molecule for the prevention and treatment of Abdominal Aortic Aneurysm New molecule for Aortic Abdominal Aneurysm (AAA) prevention and treatment (319.3 KB ) (1 page)
  • New treatment of chronic kidney disease based on the minimization of adverse effects of Albuminuria New treatment for CKD_minimizing albuminuria adverse effects (345 KB ) (1 page)
  • Treatment of kidney disease based on the state of histones Renal disease treament based on histone status (311.9 KB ) (1 page)
  • New technology to facilitate the recovery of hematpoietic stem cells after bone marrow transplantation HEMATOPOIETIC STEM CELL (166.1 KB ) (1 page)
  • New gene therapy for the treatment of PKD PKD GENE EDITING (93.2 KB ) (1 page)
  • New gene therapy for the treatment of Epidermolysis Bullosa EPIDERMOLYSIS BULLOSA (124.7 KB ) (1 page)
  • Cbase aptamers for the development of pharmacos associated with G protein-coupled receptors GPCRA RECEPTOR AGONIST APTAMERS (136.1 KB ) (1 page)
  • In vivo lentiviral gene therapy for the treatment of primary hyperoxaluria type I IN VIVO LENTIVIRAL GENE THERAPY FOR THE TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (106.5 KB ) (1 page)
  • Lentiviral vectors and their uses LENTIVIRAL VECTORS AND THEIR USES (107.3 KB ) (1 page)
  • SEPT6-ABL2 Fusion for use in the diagnosis and/or treatment of cancer SEPT6-ABL2 FUSION (508 KB ) (2 pages)
  • Bacteriophages: Pulmonary and infectious deseases. BACTERIOPAHES_PULMONARY AND INFECTIOUS DESEASES (470.1 KB ) (2 pages)
  • SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES (490.5 KB ) (1 page)
  • Treatment Meibomian Gland Dysfunction Treatment Meibomian Gland Dysfunction (578.1 KB ) (2 pages)
banner quironsalud gris
Hospital Universitario Fundación Jiménez Díaz

Fundación Jiménez Díaz

Avda. Reyes Católicos, 2
28040 Madrid

91 550 48 00
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

C/ del Maestro Ángel Llorca, 6. Bajo B. Edificio alto. 28003-Madrid (España)
28015 Madrid

91 550 48 97investigacion@fjd.es
  • Legal notice
  • Data protection
  • Cookies policy
  • Accessibility
  • Site Map
  • twitter This link will open in a pop-up window.
  • facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
  • TikTok Link to external application.

© 2025 Quirónsalud - All rights reserved

Health Research Institute accredited by the Carlos III Health Institute

Logo ISCIII